Duodenal-jejunal bypass brings an acceptable glycemic control when added to sleeve gastrectomy in Duodenal-jejunal bypass with sleeve gastrectomy.This approach combines the principles and advantages of sleeve gastrectomy and a duodenal switch.There is not enough reported evidence following DJB-SG in diabetic patients with BMI less than 30.
The aim of this study was to evaluate the effect of DJB-SG on type 2 diabetes remission in patients with BMI less than 30.
In this study we did DJB-SG for 20 patients who suffered from type 2 diabetes with BMI less than 30.All patients had a normal fasting c- peptide with acceptable post prandial c-peptide rising (>20% rise) in our private hospital from October 2016 to October 2018.
Complication rates,weight loss,and remission of diabetes and co-morbidities were evaluated and analyzed at 1,3,6 and 12 month after surgery.
Twenty diabetic patients were entered the study,12 males and 8 females,while 11 of them were insulin dependent.Mean age was 48.7 ± 10.3 years,and the duration of diabetes was 10.5 ± 9.3 months.
Evaluation of the results preoperative and 12 months after surgery:BMI 28.4 ± 1.8 vs 23.8 ± 1.7 kg/m2,fasting plasma glucose (FPG) 156.9 ± 31.2 vs. 95.7 ± 6 mg/dL, HbA1c 8.26 ± 1.8 vs 6.1 ± 0.7%,were all statistically significant (p value < 0.05). This study showed, combining duodenal switch with sleeve gastrectomy is highly effective in control of diabetes and metabolic syndrome in non-obese patients (BMI < 30).Further evaluation on more cases with longer follow-ups is essential.
- For Download click the link below.